A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Mereo Biopharma Group Plc ADR’s current trading price is -50.40% away from its 52-week high, while its distance from the 52-week low is 7.33%. The stock’s price range for this time frame has been between $2.32 and $5.02. The trading volume of the company’s shares in the Healthcare reached around 1.77 million for the day, which was evidently higher than the average daily volume of 1.17 million over the last three months.
Mereo Biopharma Group Plc ADR’s stock has had a tumultuous market performance.
How Financial Performance Impacts Market Capitalization
Mereo Biopharma Group Plc ADR (MREO) has experienced a quarterly decline of -30.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 385.28M and boasts a workforce of 33 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.53, with a change in price of -1.76. Similarly, Mereo Biopharma Group Plc ADR recorded 993,286 in trading volume during the last 100 days, posting a change of -41.41%.
How MREO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MREO stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.01.
MREO Stock Stochastic Average
Mereo Biopharma Group Plc ADR’s raw stochastic average for the past 50 days is currently at 14.72%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 23.88%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 12.10% and 8.81%, respectively.
MREO Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -28.86%. However, over the last six months, the performance has been stronger by -45.63%. The price of MREO decreased -17.28% over the last 30 days. And in the last five days, it has fallen by -1.19%.
